EFFECT OF CERTOLIZUMAB PEGOL ON THE MULTIPLE FACETS OF PSORIATIC ARTHRITIS AS REPORTED BY PATIENTS: 24-WEEK PATIENT REPORTED OUTCOME RESULTS OF A PHASE 3 DOUBLE BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY

被引：1

作者：

Gladman, D. ^{[1
]}

Fleischmann, R. ^{[2
]}

Coteur, G. ^{[3
]}

Woltering, F. ^{[4
]}

Mease, P. ^{[5
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Metroplex Clin Res Ctr, Dallas, TX USA

[3] UCB Pharma, Brussels, Belgium

[4] UCB Pharma, Monheim, Germany

[5] Swedish Med Ctr, Seattle, WA USA

来源：

关键词：

D O I：

10.1016/j.jval.2013.03.1151

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A227 / A227

页数：1